20% of those who take Paxlovid experience rebound COVID-19, study says
Paxlovid helps prevent severe COVID-19, but it also might significantly increase a person's risk of a rebound case, a new study confirms.
Stay updated with breaking news from Mark Siedner. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Paxlovid helps prevent severe COVID-19, but it also might significantly increase a person's risk of a rebound case, a new study confirms.
While US pharma Pfizer’s antiviral Paxlovid remains a lifesaving drug, a new study showed that one in five individuals experienced Covid rebound.
Covid-19 rebound, when the virus increases in the body after initially decreasing, affected just under 21 per cent of people after they took Paxlovid in a trial, compared with fewer than 2 per cent not on the treatment
According to a new study, one in five people who take Paxlovid to treat COVID-19 end up having a rebound infection.
Paxlovid helps prevent severe COVID-19, but it also might significantly increase a person's risk of a rebound case, a new study confirms.